BioProtect: Funding, Investors & Team (Sep 2026)
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.
BioProtect has raised $25.0M across 1 funding round on record, the most recent an undisclosed round of $25.0M announced in Sep 2020.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
BioProtect Company Profile and Key Stats
Latest funding round on record: Sep 2020.
BioProtect Funding Rounds
BioProtect Founders and Leadership Team
Contact details for the BioProtect team: 1 of 1 has an email address on file.
Start 14-day free trial →BioProtect Funding Compared to Other Health Care Startups
BioProtect's latest round of $25.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioProtect in Health Care and Tsur Moshe
Companies Similar to BioProtect
QuantHealth is an organization that produces software using artificial intelligence technology for drug…
Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory…
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and…
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma…
Vortex Imaging develops medical imaging devices.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and…
VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for…
Fize Medical is a health care company based in Israel.
Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation,…
TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide…
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox…
Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They…
BioProtect Funding FAQs
What does BioProtect do?
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.
How much funding has BioProtect raised?
BioProtect has raised $25.0M across 1 round on record. The most recent is an undisclosed round of $25.0M announced in Sep 2020.
When did BioProtect last raise funding?
BioProtect's most recent funding round on record is an undisclosed round of $25.0M, announced in Sep 2020.
Who is the CEO of BioProtect?
Gil Rosen is listed as CEO at BioProtect.
Where is BioProtect headquartered?
BioProtect is based in Tsur Moshe, Hamerkaz, Israel.
How many employees does BioProtect have?
BioProtect is in the 11-50 employee band.
How does BioProtect's funding compare to other Health Care startups?
BioProtect's latest round of $25.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's BioProtect Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioProtect is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.